get coin crypto Top Featured

On December 13th, Shaanxi Supervision Bureau of the State Financial Supervision and Administration issued an administrative penalty message showing that Baoji Central Branch of Ancheng Property Insurance Co., Ltd. was fined 60,000 yuan for giving benefits other than the insurance contract. The salesman of Baoji Central Branch of Ancheng Property Insurance Co., Ltd. was warned and fined 10,000 yuan.Bei Ya raised the Amazon target price from $220.00 to $260.00.Market News: Austria provides 1,000 euros to Syrian refugees to help them return home.

News before the US stock market, ① The three major stock index futures of the US stock market rose together, and crude oil futures rose by more than 1%. Today, the US import/export price index for November was announced. ② As of press time, Dow futures rose 0.26%, S&P 500 futures rose 0.36%, and Nasdaq futures rose 0.73%. (3) Germany's DAX index rose by 0.47%, Britain's FTSE 100 index rose by 0.15%, France's CAC40 index rose by 0.38% and Europe's Stoxx 50 index rose by 0.46%. ④WTI crude oil rose 1.19% to 70.85 USD/barrel. Brent crude oil rose 1.16% to $74.26/barrel. ⑤ Societe Generale warned that the recession index of 75-year winning streak indicates that the United States may be in recession. Behind the record high of American stock market, there is a trend that worries Wall Street strategists: fewer and fewer stocks support the stock market. ⑦ Xpeng Motors fell more than 3.5% before trading and was downgraded to "sell" by UBS. ⑧ Broadcom rose about 14% before the market, and the company's Q4 profit exceeded expectations. Pet-name ruby ZTO Express rose more than 1% before trading, and the average monthly express business volume in China reached 14 billion pieces.Huabei Pharmaceutical Co., Ltd.: Four kinds of drugs under the company are planned to be selected for national centralized drug procurement. Huabei Pharmaceutical announced that the company and its subsidiary Xiantai Company participated in the tenth batch of national centralized drug procurement, and all four varieties are planned to be selected, including penicillin sodium for injection, piperacillin sodium for injection, ampicillin sodium for injection and sulbactam sodium for injection. The price of the drug to be selected this time has decreased compared with the original sales price. In 2023, the sales income of penicillin sodium for injection was 129 million yuan, accounting for 1.28% of the annual operating income. If the bid is confirmed and the purchase and sale contract is signed, the company will fully guarantee the supply according to the demand of the selected area, and promote the increment of related products in the selected area and the development of the off-standard market.Joint Statement by the Foreign Ministers of People's Republic of China (PRC) and the Arab Republic of Egypt (full text) and Joint Statement by the Foreign Ministers of People's Republic of China (PRC) and the Arab Republic of Egypt 1. On December 13, 2024, Commissioner the Political Bureau of the Communist Party of China (CPC) Central Committee and Foreign Minister Wang Yi held a strategic dialogue with Egyptian Minister of Foreign Affairs and Immigration Abdul Atti. 2. The two sides exchanged in-depth and comprehensive views on China-Egypt relations and international and regional issues of common concern, and jointly reviewed the development achievements made by the two countries since the establishment of diplomatic relations, especially since the establishment of a comprehensive strategic partnership 10 years ago. 3. The two sides stressed the need to implement the important consensus reached by the two heads of state at their two meetings in 2024, take the "China-Egypt Year of Partnership" as a new starting point, and push bilateral relations to a higher goal of building a community of destiny between China and Egypt facing the new era. The two sides appreciated the many diplomatic, economic, trade, investment, cultural and tourism activities held by the two countries this year to promote and develop bilateral relations in various fields. (Xinhua News Agency)

Huitai Medical: Using raised funds and self-owned funds to increase capital of 700 million yuan to wholly-owned subsidiaries. Huitai Medical announced that the company held the 20th meeting of the second board of directors and the 17th meeting of the second board of supervisors on December 12, 2024, and reviewed and approved the Proposal on Using raised funds and self-owned funds to increase capital to wholly-owned subsidiaries. The company agreed to increase its capital by 700 million yuan to Shanghai Hongtong Industrial Co., Ltd., a wholly-owned subsidiary, of which 438 million yuan of interest-bearing loans provided to Shanghai Hongtong with raised funds were converted into capital increase, and 262 million yuan was increased with its own funds. After the capital increase is completed, the registered capital of Shanghai Hongtong will increase from RMB 18,489,300 to RMB 26,548,200, and it will remain a wholly-owned subsidiary of the company.Guoyuan Securities: A special dividend plan was drawn up and announced by Guoyuan Securities. On December 13, 2024, the company held the 20th meeting of the 10th Board of Directors and the 11th meeting of the 10th Board of Supervisors, at which the Proposal on Special Dividend Plan was reviewed and approved. As of September 30, 2024, the accumulated undistributed profit of the company was 7.743 billion yuan, and the accumulated distributable profit of the parent company was 5.262 billion yuan. In order to enhance the investor's sense of gain and improve the investor's return level, the company has drawn up a special dividend plan: based on the existing total share capital of 4.364 billion shares, a cash dividend of 0.60 yuan will be distributed to all shareholders for every 10 shares, and a total cash dividend of 262 million yuan will be distributed. No bonus shares will be distributed, and capital will not be increased from the provident fund.GCL Technology: It is estimated that there will be no more share repurchase cancellation in 2024. GCL Technology (03800) announced that in view of the fact that the photovoltaic industry is still in excessive competition, in order to ensure the stability of the company's operation and cope with the uncertainty in the future, the company expects that there will be no more share repurchase cancellation in the year ending December 31, 2024.